entertainment -WSS

entertainment

author：fashion 2025-10-01 14:19:55 - browse：44

Sammy Kimball for STAT

What can Homer teach us about biotech? Has Big Science gotten too big? And what’s the future of treating Alzheimer’s disease?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. We also discuss the latest news in the life sciences, including the abrupt resignation of the celebrity scientist who led Stanford University and the implications of tornado damage at a Pfizer plant.

For more on what we cover, here’s the news on BridgeBio; here’s more on the Stanford president; here’s the latest on the Pfizer plant; here’s the story on Eli Lilly’s Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Biotech stock slump in 2023: awaiting the turnaround

WSS

Xenotransplantation trials will require adjusting expectations, experts say

It's been 20 years since Dolly the sheep. Where's my clone?

Biden administration plans revamp of organ transplant system

Mom launches Girl Scout troop for LGBTQ youth in Texas

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Millions may soon lose Medicaid when they don't have to

entertainment

entertainment

explore

Anesthesiologist group: stop taking Ozempic before surgery

Biogen nominates mother of director’s child to replace him on board

As demand for Covid shots wanes, Moderna seeks its next success

Emergency workers more likely to restrain Black patients: study

The cancer drug shortage isn’t new — and neither are the solutions

Can medical device makers keep up in the race to treat obesity?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Millions may soon lose Medicaid when they don't have to

23andMe had bad news about my health. I wish a person had delivered it

Second xenotransplant done with gene

focus

Ukraine and a new approach to mental health in war

Eli Lilly’s Mounjaro succeeds in second weight

Biogen nominates mother of director’s child to replace him on board

A public health expert passes on football's full body collisions for youths

Ukraine and a new approach to mental health in war

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

explore

leisure time

leisure time

entertainment